▪ Vetter celebrates its second consecutive year earning this award in six categories  with three additional honors in the CDMO Leadership Awards 

▪ The results reflect the continuous effort taken every day to meet the high  expectations and requirements of its customers 

▪ Gaining champion status for quality, expertise, and compatibility, reaffirms the  performance and the level of service the CDMO is offering

“Our organizational-wide mission is to provide patients around the world with high quality  medications,” shared Vetter Managing Director Peter Soelkner. “We support our customers on  their challenging path from early clinical development of their injectable drug candidates through  regulatory approvals, to commercial production and long-term market supply. Receiving  recognition as a leader in expertise, quality, reliability and service, to name a few, attests to the  fact that we are meeting our common goals as a company very well.”  

“Above all, this prestigious honor indicates that every one of our 6,000 employees brings a  mindset driven by service and dedication to work each day – through that, we share a common  understanding of unprecedented and robust internal processes,” explained Vetter Managing  Director Thomas Otto. “This award is based on customer feedback which proves to us that our processes are working well.” 

The CDMO Leadership Awards program offers a unique representation of the service provided  to customers, as they are chosen according to customer evaluations of service providers, they  have worked with in the past 18 months.  

“Congratulations to the 2023 CDMO Leadership Award winners. You served our industry – and  patients around the world – through some turbulent and unsettled times and rose above all  others in meeting supply-chain and innovation challenges, and effectively advancing new  platforms, technologies, and products. An award in any category – capabilities, compatibility,  expertise, quality, reliability, and service – is one you and all your customers should be proud  of,” says Louis Garguilo, Chief Editor and Conference Chair, Outsourced Pharma.